参考文献/References:
[1] Van Der Salm SM, Van RA, Cath DC, et al. Clinical decision-making in functional and hyperkinetic movement disorders[J]. Neurology, 2017, 88(2): 118-123.
[2] Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders[J]. JAMA Neurol, 2018, 75(9): 1132-1141.
[3] Lafaver K, Lang EA, Stone J, et al. Opinions and clinical practices related to diagnosing and managing functional(psychogenic)movement disorders: changes in the last decade[J]. European Journal of Neurology, 2020, 27(6): 975-984.
[4] Stone J. Unfeignable biomarkers in functional neurological disorder: drifting back to Pierre Janet[J]. Brain, 2020, 143(2): 393-395.
[5] Stone J, Carson A, Duncan R, et al. Who is referred to neurology clinics?—the diagnoses made in 3781 new patients[J]. Clin Neurol Neurosurg, 2010, 112(9): 747-751.
[6] Harris SR. Psychogenic movement disorders in children and adolescents: an update[J]. Eur J Pediatr, 2019, 178(4): 581-585.
[7] Batla A, Stamelou M, Edwards MJ, et al. Functional movement disorders are not uncommon in the elderly[J]. Mov Disord, 2013, 28(4): 540-543.
[8] Gelauff JM, Rosmalen J, Gardien J, et al. Shared demographics and comorbidities in different functional motor disorders[J]. Parkinsonism Relat Disord, 2020, 70: 1-6.
[9] Jacob AE, Smith CA, Jablonski ME, et al. Multidisciplinary clinic for functional movement disorders(FMD): 1-year experience from a single centre[J]. J Neurol Neurosurg Psychiatry, 2018, 89(9): 1011-1012.
[10] Raymond C, Marin MF, Majeur D, et al. Early child adversity and psychopathology in adulthood: HPA axis and cognitive dysregulations as potential mechanisms[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2018, 85: 152-160.
[11] Breen DP, Rohani M, Moro E, et al. Functional movement disorders arising after successful deep brain stimulation[J]. Neurology, 2018, 90(20): 931-932.
[12] Edwards MJ, Adams RA, Brown H, et al. A bayesian account of ’hysteria’[J]. Brain, 2012, 135(Pt 11): 3495-3512.
[13] Sadnicka A, Daum C, Meppelink AM, et al. Reduced drift rate: a biomarker of impaired information processing in functional movement disorders[J]. Brain, 2020, 143(2): 674-683.
[14] Maurer CW, Lafaver K, Limachia GS, et al. Gray matter differences in patients with functional movement disorders[J]. Neurology, 2018, 91(20): e1870-e1879.
[15] Baizabal-Carvallo JF, Hallett M, Jankovic J. Pathogenesis and pathophysiology of functional(psychogenic)movement disorders[J]. Neurobiol Dis, 2019, 127: 32-44.
[16] Edwards MJ, Bhatia KP. Functional(psychogenic)movement disorders: merging mind and brain[J]. Lancet Neurol, 2012, 11(3): 250-260.
[17] Hallett M. Functional(psychogenic)movement disorders-Clinical presentations[J]. Parkinsonism Relat Disord, 2016, 22 Suppl 1(0 1): S149-S152.
[18] Espay AJ, Lang EA. Phenotype-specific diagnosis of functional(psychogenic)movement disorders[J]. Curr Neurol Neurosci Rep, 2015, 15(6): 32.
[19] Nonnekes J, Rui(ˇoverc)ka E, Serranová T, et al. Functional gait disorders: A sign-based approach[J]. Neurology, 2020, 94(24): 1093-1099.
[20] Hinson VK, Cubo E, Comella CL, et al. Rating scale for psychogenic movement disorders: scale development and clinimetric testing[J]. Mov Disord, 2005, 20(12): 1592-1597.
[21] Nielsen G, Ricciardi L, Meppelink AM, et al. A simplified version of the psychogenic movement disorders rating scale: the simplified functional movement disorders rating scale(S-FMDRS)[J]. Mov Disord Clin Pract, 2017, 4(5): 710-716.
[22] Wegrzyk J, Kebets V, Richiardi J, et al. Identifying motor functional neurological disorder using resting-state functional connectivity[J]. Neuroimage Clin, 2018, 17: 163-168.
[23] Maurer CW, Liu VD, Lafaver K, et al. Impaired resting vagal tone in patients with functional movement disorders[J]. Parkinsonism Relat Disord, 2016, 30: 18-22.
[24] Teodoro T, Meppelink AM, Little S, et al. Abnormal beta power is a hallmark of explicit movement control in functional movement disorders[J]. Neurology, 2018, 90(3): e247-e253.
[25] Kamble NL, Pal PK. Electrophysiological evaluation of psychogenic movement disorders[J]. Parkinsonism Relat Disord, 2016, 22( Suppl 1): S153-S158.
[26] Fahn S, Williams DT. Psychogenic dystonia[J]. Adv Neurol, 1988, 50: 431-455.
[27] Shill H, Gerber P. Evaluation of clinical diagnostic criteria for psychogenic movement disorders[J]. Mov Disord, 2006, 21(8): 1163-1168.
[28] Gupta A, Lang AE. Psychogenic movement disorders[J]. Curr Opin Neurol, 2009, 22(4): 430-436.
[29] Espay AJ, Ries S, Maloney T, et al. Clinical and neural responses to cognitive behavioral therapy for functional tremor[J]. Neurology, 2020, 95(19): 890.
[30] Taib S, Ory-Magne F, Brefel-Courbon C, et al. Repetitive transcranial magnetic stimulation for functional tremor: A randomized, double-blind, controlled study[J]. Mov Disord, 2019, 34(8): 1210-1219.
[31] Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation[J]. J Neurol Neurosurg Psychiatry, 2015, 86(10): 1113-1119.
[32] Dreissen YM, Dijk JM, Gelauff JM, et al. Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders:a double-blind,randomised placebo-controlled trial with an open-label extension[J]. J Neurol Neurosurg Psychiatry, 2019, 90(11): 1244-1250.